Substance / Medication

Tropicamide

Overview

Active Ingredient
tropicamide
RxNorm CUI
10869

Indications

For mydriasis and cycloplegia for diagnostic procedures.

Labeler: Sportpharm LLCUpdated: 2026-02-06T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Contraindicated in persons showing hypersensitivity to any component of this preparation.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

7 trials linked to this intervention

7
Total Trials
0
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Tropicamide Versus Cyclopentolate for Cycloplegic Refraction in Pediatric Patients With Brown Irides: A Randomized Clinical Trial.
Al-Thawabieh Wejdan, Al-Omari Rami, Abu-Hassan Diala Walid et al. · Am J Ophthalmol · 2024
PMID: 37797867RCT
Short-term effects of cyclopentolate and tropicamide eye drops on macular choroidal thickness in myopic children.
Kobia-Acquah Emmanuel, Flitcroft Daniel Ian, Lingham Gareth et al. · Ophthalmic Physiol Opt · 2024
PMID: 38037443RCT
Comparison of effects of mydriatic drops (1% cyclopentolate and 0.5% tropicamide) on anterior segment parameters.
Tasci Yelda Yildiz, Yesilirmak Nilufer, Yuzbasioglu Sema et al. · Indian J Ophthalmol · 2021
PMID: 34146033RCTFull text (PMC)
The effects of tropicamide and cyclopentolate hydrochloride on laser flare meter measurements in uveitis patients: a comparative study.
Yilmaz Medine, Guven Yilmaz Suzan, Palamar Melis et al. · Int Ophthalmol · 2021
PMID: 33200390RCT
Effects of two concentrations of topical tropicamide on the Schirmer tear test in clinically normal cats.
Selk Ghaffari Masoud, Javadzadeh Reza, Rajaei Seyed Mehdi · J Feline Med Surg · 2016
PMID: 26316517RCTFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tropicamide (substance)
SNOMED CT
387526001
UMLS CUI
C0041190
RxNorm CUI
10869
Labeler
Sportpharm LLC

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
7
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.